summary
Introduced
10/07/2021
10/07/2021
In Committee
10/07/2021
10/07/2021
Crossed Over
Passed
Dead
01/03/2023
01/03/2023
Introduced Session
117th Congress
Bill Summary
A BILL To amend the Federal Food, Drug, and Cosmetic Act to allow manufacturers and sponsors of a drug to use alter- native testing methods to animal testing to investigate the safety and effectiveness of a drug, and for other purposes.
AI Summary
This bill, the FDA Modernization Act of 2021, amends the Federal Food, Drug, and Cosmetic Act to allow drug manufacturers and sponsors to use alternative testing methods, such as cell-based assays, organ chips, computer models, and other non-animal or human biology-based test methods, to investigate the safety and effectiveness of a drug, in addition to traditional animal testing. The bill defines "nonclinical test or study" to include these alternative methods, as well as animal tests, that occur before or during the clinical trial phase of drug investigation.
Committee Categories
Health and Social Services
Sponsors (16)
Rand Paul (R)*,
Cory Booker (D),
Mike Braun (R),
Susan Collins (R),
Mike Crapo (R),
Tim Kaine (D),
John Neely Kennedy (R),
Angus King (I),
Mike Lee (R),
Ben Ray Luján (D),
Roger Marshall (R),
Alex Padilla (D),
Marco Rubio (R),
Bernie Sanders (I),
Rick Scott (R),
Sheldon Whitehouse (D),
Last Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 10/07/2021)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/117th-congress/senate-bill/2952/all-info |
| BillText | https://www.congress.gov/117/bills/s2952/BILLS-117s2952is.pdf |
| Bill | https://www.congress.gov/117/bills/s2952/BILLS-117s2952is.pdf.pdf |
Loading...